Nokdirna (Desmopressin)

Desmopressin, the active ingredient in Nokdirna, is a vasopressin analog presented as a sublingual formulation for sublingual use. It is employed to manage conditions characterized by excessive urine output and certain bleeding disorders.\n\nGNH India supplies Nokdirna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to correct water balance and improve clotting factor release.\n\nCentral diabetes insipidus: reduces excessive urine output by increasing water reabsorption in the kidneys.\nNocturnal enuresis: decreases nighttime bedwetting by concentrating urine.\nHemophilia A: raises plasma levels of factor VIII to aid clot formation.\nvon Willebrand disease: enhances release of von Willebrand factor, improving platelet adhesion.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often resolving without intervention.\n- Nausea: transient upset stomach or feeling of queasiness.\n- Nasal congestion: mild blockage or runny nose.\n- Mild hyponatremia: slight reduction in blood sodium that is usually asymptomatic.\n\nSerious or Rare Side Effects:\n- Severe hyponatremia: marked low sodium that can lead to confusion, seizures or coma.\n- Water intoxication: excessive fluid retention causing swelling and electrolyte imbalance.\n- Allergic reactions: rash, itching, swelling or difficulty breathing.\n- Thrombotic events: rare clot formation in blood vessels.

Desmopressin requires careful monitoring to avoid fluid and electrolyte disturbances.\n\nMonitor serum sodium: check levels regularly, especially in the elderly or those on diuretics.\nAdjust dose in renal impairment: reduce dosage if kidney function is compromised.\nCaution in elderly patients: increased susceptibility to hyponatremia and fluid overload.\nAvoid concurrent ADH analogs: additive antidiuretic effect may precipitate severe hyponatremia.\nReview fluid intake: advise patients to limit excessive water consumption.\nStore at ambient temperature: keep in the original packaging, protect from moisture and light.

Desmopressin can interact with several drug classes, altering its efficacy or safety profile.\n\nMajor Interactions (Avoid):\n- Other ADH analogs: additive antidiuretic effect may cause dangerous hyponatremia.\n- MAO inhibitors: increased risk of severe hyponatremia.\n- Carbamazepine: reduces desmopressin effectiveness by enhancing its metabolism.\n\nModerate Interactions (Monitor Closely):\n- Diuretics: may exacerbate fluid and electrolyte shifts.\n- SSRIs and other antidepressants: heightened risk of hyponatremia.\n- ACE inhibitors: potential for additive sodium loss and hypotension.